Home > Boards > Other Markets > Foreign Stock Markets > B.R.A.I.N. Biotechnology Research And Information Network

I'd like to share this German-based biotech company

Public Reply | Private Reply | Keep | Last ReadPost New MsgPrevious | Next
downtrade Member Profile
 
Followed By 1
Posts 56
Boards Moderated 0
Alias Born 03/13/13
160x600 placeholder
downtrade   Thursday, 08/16/18 07:14:18 AM
Re: None
Post # of 1 
I'd like to share this German-based biotech company with you as I personally think B.R.A.I.N. could have a great future in the field of white/industrial biotech solutions. It is one of the key players in Europe in the field of white biotechnology and is very well positioned to lead the growing industrial biotech market.

I first heard about it during my Masters Studies back in 2011 and discovered a few weeks ago that it had its IPO in 2016. German media has covered the company and its potential recently and the emphasis is clearly on the huge potential side with existing and upcoming microorganism-based products in markets like chemical, cosmetics, food and medical technology industries.
One further focus of BRAIN is the emerging market of green mining with microorganism based mining of gold, silver etc. without costly chemicals for mining companies. Market launch is expected to be in 2019.

BRAIN has two main business pillars:

1. BioSciences: strategic cooperation
Together with strategic partners from the target industry, BRAIN on the basis of exclusive license agreements in R&D cooperation programs has identified previously untapped, efficient enzymes, microbial producer organisms or natural substances from complex biological systems that can be put to industrial use. The company aims to replace classical chemical and industrial processes with novel and resource-saving processes, and to establish new processes and products.

2. BioIndustrial: the development of our own products
The industrialization strategy, which was successfully launched in 2010 as the company’s second pillar of operation next to the co-operation business, has been expanded successfully with an established M&A strategy. It permits BRAIN AG to access the BRAIN Group’s entire value chain of different lucrative markets, from the identification of biological solutions and their development to their implementation in the target industries. Currently, the BRAIN Group consists of the following companies, all of which operate successfully in the market:
Analyticon Discovery GmbH
Biocatalysts Limited
L.A. Schmitt GmbH Chem.-Kosmetische Fabrik
MONTEIL COSMETICS INTERNATIONAL GmbH
WeissBioTech GmbH.


----

I am not a financial advisor and I started this board to begin discussions on this exciting company.

Public Reply | Private Reply | Keep | Last ReadPost New MsgPrevious | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist